95 related articles for article (PubMed ID: 10751550)
1. Modification of the plasma clearance and liver uptake of steroid ester-conjugated oligodeoxynucleotides by association with (lactosylated) low-density lipoprotein.
Rump ET; de Vrueh RL; Manoharan M; Waarlo IH; van Veghel R; Biessen EA; van Berkel TJ; Bijsterbosch MK
Biochem Pharmacol; 2000 Jun; 59(11):1407-16. PubMed ID: 10751550
[TBL] [Abstract][Full Text] [Related]
2. Preparation of conjugates of oligodeoxynucleotides and lipid structures and their interaction with low-density lipoprotein.
Rump ET; de Vrueh RL; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
Bioconjug Chem; 1998; 9(3):341-9. PubMed ID: 9576808
[TBL] [Abstract][Full Text] [Related]
3. Lactosylated low density lipoprotein: a potential carrier for the site-specific delivery of drugs to Kupffer cells.
Bijsterbosch MK; Ziere GJ; Van Berkel TJ
Mol Pharmacol; 1989 Sep; 36(3):484-9. PubMed ID: 2550781
[TBL] [Abstract][Full Text] [Related]
4. bis-Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides are highly selectively taken up by the liver.
Bijsterbosch MK; Manoharan M; Dorland R; Van Veghel R; Biessen EA; Van Berkel TJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):619-26. PubMed ID: 12130724
[TBL] [Abstract][Full Text] [Related]
5. Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors.
Biessen EA; Vietsch H; Kuiper J; Bijsterbosch MK; Berkel TJ
Mol Pharmacol; 1998 Feb; 53(2):262-9. PubMed ID: 9463484
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides.
Lischka K; Starke D; Failing K; Herling A; Kramer W; Petzinger E
Biochem Pharmacol; 2003 Aug; 66(4):565-77. PubMed ID: 12906921
[TBL] [Abstract][Full Text] [Related]
7. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.
Bijsterbosch MK; Van Berkel TJ
Biochem J; 1990 Aug; 270(1):233-9. PubMed ID: 1697748
[TBL] [Abstract][Full Text] [Related]
8. Delivery of cholesteryl-conjugated phosphorothioate oligodeoxynucleotides to Kupffer cells by lactosylated low-density lipoprotein.
Bijsterbosch MK; Manoharan M; Dorland R; Waarlo IH; Biessen EA; van Berkel TJ
Biochem Pharmacol; 2001 Sep; 62(5):627-33. PubMed ID: 11585059
[TBL] [Abstract][Full Text] [Related]
9. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins.
Mahley RW; Innerarity TL; Weisgraber KB; Oh SY
J Clin Invest; 1979 Sep; 64(3):743-50. PubMed ID: 224077
[TBL] [Abstract][Full Text] [Related]
10. Lactosylated high density lipoprotein: a potential carrier for the site-specific delivery of drugs to parenchymal liver cells.
Bijsterbosch MK; Van Berkel TJ
Mol Pharmacol; 1992 Feb; 41(2):404-11. PubMed ID: 1311413
[TBL] [Abstract][Full Text] [Related]
11. Selective association of lipoprotein cholesteryl esters with liver plasma membranes.
Rinninger F; Jaeckle S; Greten H; Windler E
Biochim Biophys Acta; 1993 Feb; 1166(2-3):284-99. PubMed ID: 8443247
[TBL] [Abstract][Full Text] [Related]
12. Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells.
Fluiter K; Vietsch H; Biessen EA; Kostner GM; van Berkel TJ; Sattler W
Biochem J; 1996 Oct; 319 ( Pt 2)(Pt 2):471-6. PubMed ID: 8912683
[TBL] [Abstract][Full Text] [Related]
13. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution.
de Smidt PC; Le Doan T; de Falco S; van Berkel TJ
Nucleic Acids Res; 1991 Sep; 19(17):4695-700. PubMed ID: 1891360
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.
Biessen EA; Vietsch H; Rump ET; Fluiter K; Kuiper J; Bijsterbosch MK; van Berkel TJ
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):783-92. PubMed ID: 10359665
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the uptake of high-density lipoprotein-originated cholesteryl ester by HepG2 cells: role of low-density lipoprotein and plasma lipid transfer protein.
Francis GA; Ko KW; Hara H; Yokoyama S
Biochim Biophys Acta; 1991 Jul; 1084(2):159-66. PubMed ID: 1649639
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Groener JE; van Gent T; van Tol A
Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of native and of lactosylated human low density lipoprotein: evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes.
Attie AD; Pittman RC; Steinberg D
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5923-7. PubMed ID: 6160586
[TBL] [Abstract][Full Text] [Related]
18. Improved systemic pharmacokinetics, biodistribution, and antitumor activity of CpG oligodeoxynucleotides complexed to endogenous antibodies in vivo.
Palma E; Cho MJ
J Control Release; 2007 Jul; 120(1-2):95-103. PubMed ID: 17509715
[TBL] [Abstract][Full Text] [Related]
19. Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis.
Pieters MN; Schouten D; Bakkeren HF; Esbach B; Brouwer A; Knook DL; van Berkel TJ
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):359-65. PubMed ID: 1747108
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.
Rensen PC; Schiffelers RM; Versluis AJ; Bijsterbosch MK; Van Kuijk-Meuwissen ME; Van Berkel TJ
Mol Pharmacol; 1997 Sep; 52(3):445-55. PubMed ID: 9281607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
